FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynecology, and can be used as a prediction of increasing uterine leiomyoma size in females of reproductive age within one year of observation. Method involves determining mononuclear cells of the endometrium located in a projection of the myomatous node, the relative content of CD36+ macrophages in a macrophage gate. If the value is less than 22 %, the uterine leiomyoma size is predicted, and if the value is more than 22 %, a stable uterine leiomyoma size is predicted.
EFFECT: use of the given method enables predicting a risk of increasing uterine leiomyoma size, which enables to maximally preserve the reproductive function of women by optimizing the choice of conservative and surgical methods.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
METHOD FOR DIAGNOSING PROLIFERATIVE ACTIVITY OF UTERINE LEIOMYOMA CELLS | 2019 |
|
RU2700003C1 |
METHOD OF PREDICTING OF FAST GROWTH OF LEIOMYOMA OF UTERUS | 2007 |
|
RU2340897C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF LEIOMYOMA GROWTH PATTERNS | 2013 |
|
RU2542468C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UTERUS LEIOMYOMA GROWTH TYPE | 2008 |
|
RU2361216C1 |
METHOD FOR PREDICTING GROWTH RATE OF UTERINE LEIOMYOMA IN WOMEN OF REPRODUCTIVE AGE | 2018 |
|
RU2690379C1 |
METHOD OF DETECTING HEREDITARY PREDISPOSITION TO FAST GROWTH OF UTERINE MYOMA | 2011 |
|
RU2475740C1 |
METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SIMPLE AND FAST-GROWING HYSTEROMYOMA WITH NORMAL ENDOMETRIAL STRUCTURE | 2013 |
|
RU2554824C1 |
METHOD FOR RAPID HYSTEROMYOMA DEVELOPMENT PREDICTION | 2016 |
|
RU2626676C1 |
Authors
Dates
2019-10-31—Published
2019-07-09—Filed